RGNX is currently covered by 7 analysts with average potential upside of $20.15 (62.45%) backed by 50 price targets and 75 ratings. Documented since 20-Oct-2015. Analyst's average stock valuation to be materialised ratio is 30.86% with an average time for price targets to be met of 80.77 days.
Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 06-Mar-2023.
Highest price target for RGNX is 46, Lowest price target is 19, average price target is 32.5.
Currently, out of the existing stock ratings of RGNX - 14 which are a Hold (48.28%), 15 which are a Buy (51.72%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
46
$26.64 (137.60%)
50
22 days ago
2/18 (11.11%)
$18.11 (53.07%)
37
Buy
61
$41.64 (215.08%)
26 days ago
0/1 (0%)
$37.46 (159.13%)
Hold
14
$-5.36 (-27.69%)
14
2 months 5 days ago
12/15 (80%)
$-2.25 (-4.92%)
40
Buy
61
$39.29 (180.98%)
4 months 24 days ago
0/1 (0%)
$40.27 (194.26%)
Hold
29
$9.64 (49.79%)
55
5 months 24 days ago
1/7 (14.29%)
$11.11 (31.31%)
8
What is RGNX(REGENXBIO Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RGNX(REGENXBIO Inc) with a proven track record?
